If you typed Genexion into a search box, you are probably building a CRO or site shortlist for Peru. This article uses only what is public about Genexion (INS register of research organizations (OIC)) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.
What Genexion publishes
Genexion S.A.C. (Genexion Perú) is a Lima-based (Miraflores) research organization registered in the INS register of research organizations (OIC) (ROIC-200/315). We did not find a current company website. Public INS trial listings associate it with Phase III drug research.
Genexion vs bioaccess®
| Dimension | Genexion | bioaccess® |
|---|---|---|
| Core focus | Peru drug research organization (INS-registered) | First-in-human and early feasibility studies for medical devices |
| Geography | Peru (Lima) | Latin America, since 2010 |
| Device FIH track record | No named device first-in-human study found on the public pages reviewed | Published case studies on bioaccessla.com |
| After the trial | See provider site | Live multi-country sanitary registration and in-country holder service |
Where each one fits
If you need an INS-registered local organization for a Phase III drug study in Peru, Genexion’s public registration matches.
If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including Genexion, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.
For the Peru regulatory path, see CRO in Peru: the First-in-Human CRO on the INS file. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.
Ready to compare a proposal? Request a first-in-human study proposal.
Facts from the Genexion public pages linked above, Peru’s INS public registers and ClinicalTrials.gov, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.